Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Blerta Beluli"'
Autor:
Elias Ewais, Justus Strauch, Polykarpos C. Patsalis, Matthias Bechtel, Dritan Useini, Peter L. Haldenwang, Markus Schlömicher, Blerta Beluli, V. Moustafine, Hildegard Christ
Publikováno v:
Journal of Cardiac Surgery. 36:610-617
OBJECTIVES Little data have been published on the midterm effect of transapical/transfemoral-transcatheter aortic valve replacement (TA-/TF-TAVR) using the Edwards SAPIEN 3 valve (S3). We aimed to compare the outcomes after TA-/TF-TAVR utilizing the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d064a92c4cfec82f17d786c17592953b
https://doi.org/10.1111/jocs.15275
https://doi.org/10.1111/jocs.15275
Autor:
Markus Schlömicher, Matthias Bechtel, Peter L. Haldenwang, Blerta Beluli, Dritan Useini, Justus Strauch
Publikováno v:
The Annals of Thoracic Surgery. 110:e189-e192
The Edwards INTUITY aortic valve has in recent years played a significant role in facilitating surgical aortic valve replacement. Owing to the excellent hemodynamic characteristics and relatively new usage of this bioprosthetic aortic valve, the stru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::930e692a3686a464e8532926e2efccd2
https://doi.org/10.1016/j.athoracsur.2020.01.029
https://doi.org/10.1016/j.athoracsur.2020.01.029
Autor:
Justus Strauch, Peter L. Haldenwang, Dritan Useini, Andreas Mügge, Blerta Beluli, Markus Schlömicher, Matthias Bechtel, Hildegard Christ, Polykarpos C. Patsalis
Publikováno v:
The Thoracic and Cardiovascular Surgeon. 69:445-454
Background A certain degree of prosthesis oversizing is recommended for the SAPIEN 3 (S3; Edwards Lifesciences Corp., Irvine, California, United States) to ensure device success. We aimed to investigate midterm outcomes in patients who received overs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c270c10d243f280ed35d822a495c7227
https://doi.org/10.1055/s-0040-1713168
https://doi.org/10.1055/s-0040-1713168
Autor:
Dritan USEINI, Markus SCHLÖMICHER, Blerta BELULI, Hildegard CHRIST, Elias EWAIS, Peter HALDENWANG, Polykarpos PATSALIS, Vadim MOUSTAFINE, Matthias BECHTEL, Justus STRAUCH
Publikováno v:
The Journal of cardiovascular surgery. 62(6)
Scarcely any data has been published on the mid-term effect of transapical-transcatheter aortic valve implantation (TA-TAVI) using the Edwards SAPIEN 3 valve (S3; Edwards Lifesciences Corp., Irvine, CA, USA). We present mid-term clinical and echocard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01390a9b4904836ddf531e36a7e51e4d
https://pubmed.ncbi.nlm.nih.gov/35037446
https://pubmed.ncbi.nlm.nih.gov/35037446
Autor:
Polykarpos C. Patsalis, Blerta Beluli, Dritan Useini, Markus Schlömicher, Hildegard Christ, Peter L. Haldenwang, Justus Strauch
Publikováno v:
The Thoracic and cardiovascular surgeon. 70(3)
Introduction Though transfemoral (TF) access has emerged as a gold standard access for patients with aortic stenosis who undergo transcatheter aortic valve implantation (TAVI), there has been no study that has characterized patients who cannot underg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90844f903ba4eca0263c344da5c769ed
https://pubmed.ncbi.nlm.nih.gov/33851408
https://pubmed.ncbi.nlm.nih.gov/33851408
Publikováno v:
Journal of cardiac surgeryREFERENCES. 36(7)
OBJECTIVES Some patients who undergo transcatheter aortic valve replacement (TAVR) have a concomitant diverse aortic pathologies (AP). They are usually considered high-risk candidates for the procedure and require further assessment to determine the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08168e3112fb82dc95c791410afcd5cd
https://pubmed.ncbi.nlm.nih.gov/33783007
https://pubmed.ncbi.nlm.nih.gov/33783007
Autor:
Blerta Beluli, Peter L. Haldenwang, Markus Schlömicher, Justus Strauch, Hamid Naraghi, Hildegard Christ, Elias Ewais, Dritan Useini, V. Moustafine, Polykarpos C. Patsalis, Matthias Bechtel
Publikováno v:
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 59(6)
OBJECTIVES Patients scheduled for transcatheter aortic valve implantation (TAVI) treatment frequently present with concomitant aortic diseases, in which case they are usually considered to be at high interventional risk and, in particular, unable to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::639499b416ad7cb1d5f0c5c7720303ad
https://pubmed.ncbi.nlm.nih.gov/33772311
https://pubmed.ncbi.nlm.nih.gov/33772311